By Jessica Mooney
description
Transcript of By Jessica Mooney
Regularly Scheduled Artificial (IV) Hydration among Head and Neck Cancer Patients
Undergoing Radiotherapy-based Treatment
By Jessica MooneyWith special thanks to: Melanie Gillingham Phd, RD, Dr. John Holland, Sonja Connors PhD, RD, and Shannon
Rentz, RD
Specific Aim Effect of regular artificial
hydration on the number of admissions for clinical dehydration, and markers of nutritional status in head and neck cancer patients.
Between the OHSU patients who received regularly scheduled IV artificial hydration, with the OHSU patients who received current standard of care
Importance Cancer
Statistics of HNC Risk Factors
Delays in Treatment
Background-Treatment Radiation
50% of all cancer patients
How Radiation WorksIntensity modulated
radiation treatment (IMRT)○ 58% still suffer○ Most cost effective
treatment
http://svroa.com/services
Background-Treatment Chemotherapy
How Chemotherapy Works○ Toxicities
Combined ChemoradiationNew TrendDisease-specific
survival rates, and loco regional control.
Hospitalizations and Side Effects Malnourished prior to treatment Hospitalizations
Mucositis Hematologic toxicity Toxicity-related treatment delays
○ Of these hospitalizations
Concomitant chemotherapy and radiation
Delays in Treatment
Delays in treatment:Outpatient treatmentIncrease of total dose
ToxicitiesSalivary flow Renal functionMucositis
Prevalence of breaks and effects on treatment
Cost
Treatment of cancer significant cost$95,000 (AU) per annum for cancer
treatment and preventing severe side effects Average cost
All grades of oral mucositis=$6000 per patient○ Grade 1-2 = $1700 per patient per visit○ Grade 3-4 = $3600 per patient per visit.
Cost Most cost efficient
method or treatment. SurgeryRadiationChemotherapy.
These costs cause financial burdens for both the patient and the healthcare facility.
Modes of Artificial Hydration Hydration and nutritional status Dehydration can cause
fatigue, lethargy, nausea, vomiting, confusion, muscle cramps, and perhaps increased mortality rates.
Determining Hydration Status Modes of Artificial Hydration
Parenteral FluidsEnteral FluidsHypodermoclysis
Quality of Life
Quality of life (QOL)Physical vs. Psychological Social Event
Questionnaires for QOL in HNCSurvey short and to the pointQualitative observations
Other Benefits of QOL surveys
Methods General Overview Oregon Health and Science University
(OHSU)
Retrospective chart review Comparing:
○ Patients before August 2011○ Patients after August 2011
Methods-Inclusion/Exclusion Table 3: Inclusion and exclusion criteria
Inclusion Exclusion>18 years old <18 years oldDiagnosis of Head and neck cancer Diagnosis other then head and neck
cancerCombination treatment (surgical and radiation)
Chemotherapy, radiation, or surgical only treatment
Patient at OHSU either prior to August 2011 or after August 2011
Current Standard of Care Patients at OHSU
currently
After August 2011Artificial hydration at
emergency department or when severely dehydrated.
Historical Standard of Care
Before August 2011
OHSU patients received regularly scheduled IV artificial hydration
Methods-Retrospective
60 OHSU patients treated with regularly scheduled artificial hydration
45 OHSU patients treated with current standard of care
The EPIC electronic medical records will be queried using the tumor registry
Power Calculations Primary outcomes of interest
Two-sided significance level of 0.05. The mean number of hospitalizations (number of
emergency department visits) anticipation Supported by Elting et al (2007)
○ average of 0.62 visits per patient over the treatment cycle.
Sample of 60 patients under the routine hydration protocol and 45 patients under the newer (no routine hydration) Provides an 80% chance of detecting at least an 85% increase in the
mean number of visits (Wald test; increase from 0.6 to 1.1 visits). BUN expectations of initial lab concentrations
Correlation between initial and final BUN is expected to be fairly weak (about 0.20).
80% power to detect mean changes of at least 2.4 mg/dL relative to baseline within either group, with the minimal effect being even smaller for the sample of 60 subjects under the older treatment protocol.
Methods-Retrospective The retrospective
chart review will compare: unplanned hospital
visitsTreatment breaksNumber of times
clinical hydration is administered
Registered Dietitian exposure during treatment
Methods Standards Set
Key outcomes
Outside of Ranges will be consideredUnacceptableDetrimental to
treatment
Methods-Retrospective
Variables Acceptable Ranges
BUN 7-25 mg/dL
Creatinine 0.7-1.4 mg/dL
Hbg 12-18 mg/dL
Hct 37-54%
Unplanned Hospital Visits 0 visits
Weight Loss Throughout Treatment
Weight loss less than 10% in 6 months
Breaks in Treatment 0-5 days
Statistical Methods Calculations
Means and standard deviations
These values will be performed using SPSS software.
Analytical Statistics
Comparisons betweenHistorical OHSU patient population that
received routine hydration Recent HNC patients who did not receive
routine hydration T-test
Values <0.05 considered statistically significant T-tests to compare our primary and
secondary outcomes Following slides
Exploratory Statistics Correlation between
weight loss with treatment, renal function and treatment outcomes
Goal: to evaluate if preventing weight loss or providing regular hydration treatment decreases hospitalizations during treatment or treatment breaks.
Statistical Methods Statistics conducted to
prove or disprove: Number of
Hospitalizations BUN/Creatinine Levels
Correlates with number of clinical hydration appointments made
Reject or support hypothesis
Key OutcomesPRIMARY OUTCOMES
Number of Hospitalizations BUN/Creatinine Serum Values
SECONDARY OUTCOMES
Breaks in Treatment Weight loss throughout treatment
Serum Hemoglobin Serum Hematocrit
Administration of Hydration (scheduled/unscheduled)
Nutrition Counseling by Registered Dietitian
Conclusion Focus of Treatment
Better coordination of care
Symptom management Promotion of more cost
effective treatments
Avoiding adverse affects that often accompany HNC and it’s treatment
Regularly Scheduled Artificial Hydration among Head and Neck Cancer Patients
Undergoing Radiotherapy-based Treatment
By Jessica Mooney